Residual Cone Structure in Patients With X-Linked Cone Opsin Mutations by Patterson, EJ et al.
Retina
Residual Cone Structure in Patients With X-Linked Cone
Opsin Mutations
Emily J. Patterson,1 Angelos Kalitzeos,2,3 Melissa Kasilian,2,3 Jessica C. Gardner,2,3 Jay Neitz,4
Alison J. Hardcastle,2,3 Maureen Neitz,4 Joseph Carroll,1,5,6 and Michel Michaelides2,3
1Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
2University College London Institute of Ophthalmology, London, United Kingdom
3Moorfields Eye Hospital, London, United Kingdom
4Department of Ophthalmology, University of Washington, Seattle, Washington, United States
5Department of Biophysics, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
6Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Correspondence: Joseph Carroll,
Department of Ophthalmology and
Visual Sciences, Medical College of
Wisconsin, 925 N. 87th Street, Mil-
waukee, WI 53226, USA;
jcarroll@mcw.edu.
Michel Michaelides, University Col-
lege London Institute of Ophthal-
mology, 11-43 Bath Street, London
EC1V 9EL, UK;
michel.michaelides@ucl.ac.uk.
Submitted: April 28, 2018
Accepted: July 13, 2018
Citation: Patterson EJ, Kalitzeos A,
Kasilian M, et al. Residual cone
structure in patients with X-linked
cone opsin mutations. Invest Oph-
thalmol Vis Sci. 2018;59:4238–4248.
https://doi.org/10.1167/iovs.18-24699
PURPOSE. To assess residual cone structure in subjects with mutations in exon 2, 3, and 4 of the
OPN1LW or OPN1MW opsin.
METHODS. Thirteen males had their OPN1LW/OPN1MW opsin genes characterized. The cone
mosaic was imaged using both confocal and nonconfocal split-detection adaptive optics
scanning light ophthalmoscopy (AOSLO), and retinal thickness was evaluated using optical
coherence tomography (OCT). Six subjects completed serial imaging over a maximum period
of 18 months and cone density was measured across imaging sessions.
RESULTS. Ten subjects had an OPN1LW/OPN1MW ‘‘interchange’’ opsin mutation designated as
LIAVA or LVAVA, which both introduce exon 3 splicing defects leading to a lack of functional
photopigment in cones expressing LIAVA and greatly reduced functional photopigment in
cones expressing LVAVA. Despite disrupted cone reflectivity and reduced numerosity, residual
inner segments could be visualized. Similar patterns were observed in individuals with an
exon 2 insertion, or an exon 4 splice defect, both of which are also expected to produce
cones that are devoid of functional opsin protein. OCT revealed variably reduced retinal
thickness. A significant inverse relationship was found between the proportion of
waveguiding cones and axial length.
CONCLUSIONS. Split-detection imaging revealed that the altered appearance of the cone mosaic
in confocal images for subjects with exon 2, 3, and 4 mutations was generally due to disrupted
waveguiding, rather than structural loss, making them possible candidates for gene therapy to
restore cone function. The relative fraction of waveguiding cones was highly variable across
subjects, which appears to influence emmetropization in these subjects.
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Bornholm eye disease (BED)
1,2 has been distinguished from
other X-linked cone dysfunction syndromes by its associ-
ation with red-green color vision deficiency, myopia, and
astigmatism, in addition to other general cone dysfunction
characteristics.3 The disease in the original Danish family and in
a Minnesota family with a similar phenotype was mapped to
Xq28 (the locus of MYP1),4 which encompasses the long (L)
and middle (M) wavelength sensitive opsin genes OPN1LW and
OPN1MW, respectively. Ultimately, the same underlying muta-
tion in the cone opsin genes, designated LVAVA, was found in
both families.5,6 This ‘‘interchange-mutation’’ is associated with
a combination of amino acids designated by the single letter
code for the amino acids specified by exon 3 codons 153, 171,
174, 178, and 180, respectively, where L is leucine, V is valine,
and A is alanine.7 Although both of the original MYP1 families
had color vision deficiencies, which was a defining feature of
BED, affected members of four additional families with X-linked
high myopia of Chinese ancestry,8–10 also mapped to MYP1,
were later found to have normal color vision. The original
(MYP1) families coincidentally had separate gene rearrange-
ments responsible for their color vision deficiency, while the
LVAVA mutation was responsible for the myopia and other cone
dysfunction symptoms. In addition to altering the amino acid
sequence, the underlying nucleotide combination introduces
an exon 3 splicing defect that greatly reduces production of
normal opsin. Cones expressing the mutant opsin appear to
function well enough to support normal color vision in younger
eyes but degenerate over time.11 The malfunctioning cones
lead to high myopia and cone degenerative symptoms in
individuals with a submosaic of LVAVA-expressing cones, along
with a submosaic of cones expressing normal pigment. The
same mutation produces progressive cone dystrophy with
significant vision loss by midlife in individuals who express
LVAVA opsin in all L/M cones.11
Some individuals diagnosed as having BED, besides those in
the original MYP1 families, were found to have a different
interchange mutation, designated LIAVA, which has isoleucine
at position 171. This mutation was originally discovered as a
cause of dichromacy in subjects who were not noted to have
any of the pathological symptoms of BED.12,13 Even though the
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LVAVA and the LIAVA genes and their encoded proteins are
similar, they produce striking differences in phenotype.14 Most
notable are (1) that no function from LIAVA cones can be
detected in psychophysical or ERG measurements, so people
expressing LIAVA are obligate dichromats (or blue cone
monochromats if all the OPN1LW/OPN1MW genes express
it), and (2) disorders associated with LIAVA appear to be spared
from some of the detrimental effects associated with LVAVA
that result from the expression of small amounts of correctly
spliced LVAVA protein, which is apparently toxic to the
cell.14,15
Confocal adaptive-optics scanning light ophthalmoscopy
(AOSLO) has been used to demonstrate variable reduction in
the density of normally waveguiding cones among subjects
with various OPN1LW/OPN1MW mutations.6,11,12,16 One
drawback of confocal AOSLO imaging is its reliance on the
ability of cone photoreceptors to effectively waveguide light,
making it difficult to ascertain whether dark areas are
indicative of cone loss or simply altered waveguiding. For
example, although numerous dark spaces are evident in
confocal retinal images from subjects with achromatopsia,12,17
nonconfocal split-detection imaging has revealed residual cone
structure within these areas.17,18 Split-detection imaging
exploits light that is multiply-scattered by the retina, which
enables visualization of the cone inner segments in a manner
thought to be independent of their waveguiding proper-
ties17,19; the simultaneous acquisition of both modalities
provides direct temporal correspondence and coaxial align-
ment ensures direct spatial correspondence between bright
spots or dark gaps in confocal images and cone structure in
split-detection images. Here we used AOSLO to characterize
cone structure in subjects harboring the LIAVA or LVAVA exon
3 haplotype, and compared these findings with subjects with
mutations in exon 2 and 4. We also examined longitudinal
changes in retinal structure using optical coherence tomogra-
phy (OCT) and AOSLO. Given the growing emergence of
therapeutic trials for cone disorders, there is an increased need
to stratify patients for potential participation and to establish
outcome measures to assess treatment efficacy20,21; the
successful use of AOSLO to examine challenging conditions
such as X-linked cone dysfunction demonstrates its potential
utility in such trials.
MATERIALS AND METHODS
Subjects
Thirteen male subjects with red-green color vision deficiency
and/or suspected X-linked cone dysfunction were recruited.
The genotype and clinical phenotype for nine of the subjects
has been reported previously (Table). The four remaining
subjects provided blood samples, from which DNA was
isolated and opsin genes were amplified and sequenced using
previously described methods.13,22 Axial length was measured
in each eye imaged using the Zeiss IOL Master (Carl Zeiss
Meditec, Dublin, CA, USA). Color vision was assessed using the
Richmond HRR (4th edition), the Rayleigh match and the
Colour Assessment and Diagnosis23 test when available. This
study followed the tenets of the Declaration of Helsinki and
was approved by local institutional review boards (MCW:
PRO17439 & PRO30741). Informed consent was obtained
from all subjects, after the nature and possible consequences
of the study were explained.
Spectral-Domain Optical Coherence Tomography
(SD-OCT)
High-resolution SD-OCT images of the macula were acquired
using the Bioptigen Envisu R2200 SD-OCT system (Leica
Microsystems, Wetzlar, Germany). High-density line scans
(either 750 or 1000 A-scans/B-scan, 100–150 repeated B scans)
were acquired through the foveal center. Line scans were
registered and averaged to reduce speckle noise in the image
and then scaled as previously described.6 Longitudinal
reflectance profiles were created from logarithmic grayscale
images using custom software—OCT Reflectivity Analytics24—
to yield measurements of total retinal thickness as well as outer
nuclear layer and Henle fiber layer (ONLþ) thickness at the
fovea.
TABLE. Summary of the Genotype and Clinical Phenotype of Subjects With X-Linked Cone Dysfunction
Subject Age, y Phenotype Genotype Mutation Type
Axial Length, mm
SourceOD OS
1 JC_0084 37 Deuteranope L - MLIAVA interchange: exon 3 25.34 25.19 Subject NC
12
2 MM_0133 29 Protanope LLIAVA - M - M interchange: exon 3 27.48 27.32 Subject B1
32 / JC_01956
3 MM_0142 15 Protanope LLIAVA - M interchange: exon 3 23.34 23.28 MM_0142
6
4 MM_0144* 19 Protanope MLIAVA - M interchange: exon 3 27.14 26.90 Subject C1
6,32
5 MM_0145* 16 Protanope MLIAVA - M† interchange: exon 3 23.57 23.59 Subject C2
6,32
6 MM_0155‡§ 30 Unclassified RG
defect
LLIAVA - M interchange: exon 3 30.74 29.51 This study
7 JC_0609 15 Protanope LLIAVA - M interchange: exon 3 29.03 29.08 JC_0609
6
8 JC_10340§ 32 Protanope MLVAVA - M - M interchange: exon 3 28.96 28.08 Subject 31
4 / JC_103406
9 JC_11437* 36 Deuteranope LLVAVA - L - M - M interchange: exon 3 25.04 23.92 Subject 96
1
10 JC_11445* 26 Deuteranope LLVAVA - L - M - M interchange: exon 3 25.79 25.65 This Study
11 MM_0156* 13 Protanope Lexon 2 insertion - M insertion: exon 2 27.90 28.24 MM_0156
6
12 MM_0157* 18 Protanope Lexon 2 insertion - M insertion: exon 2 23.69 23.57 MM_0157
6
13 MM_0188 10 Unclassified RG
defect
Lexon 4 splice defect - M splice defect: exon 4 24.99 24.89 This study
* The following subjects are brothers: MM_0144 and MM_0145; JC_11437 and JC_11445; MM_0156 and MM_0157.
† MM_0145 was not genetically sequenced; genotype was inferred from brother (MM_0144) based on their mother’s normal color vision.
‡ OCT images from MM_0155 were not analyzable.
§ AOSLO images from MM_0155 and JC_10340 were not analyzable.
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Adaptive Optics Retinal Imaging
Each eye imaged was dilated using one drop of phenylephrine
hydrochloride (2.5%) and one drop of tropicamide (1%).
Confocal and split-detection videos of the central photorecep-
tor mosaic were obtained with one of two previously
described AOSLO systems, housed either at the Medical
College of Wisconsin or at Moorfields Eye Hospital.6,17 Raw
videos were registered and averaged to produce images with a
high signal-to-noise ratio, which were then montaged as
previously described.6,25
For 10 subjects, the foveal center was identified using the
‘peak cone density’ method, as previously described.6,26
Where possible, this was achieved using confocal images;
however, the severely reduced reflectivity of foveal cones for
JC_0609 made this unfeasible, so split-detection was used. Due
to poor image quality and inability to resolve foveal cones for
MM_0156, the ‘preferred retinal locus’ method was used, as
previously described.6 For the remaining two subjects, image
quality was too poor to enable further analysis.
A semiautomated algorithm was used to mark the location
of individual cones in each 55-lm region of interest (ROI),27
and the coordinates were used to calculate cone density, when
possible, at the fovea, as well as at 0.258, 0.58, and at 18
intervals from 18 to 108 along the temporal meridian. Each ROI
was counted twice by a single observer (EJP) to assess
repeatability and the mean was used for subsequent analysis.
Follow-up data were available for six subjects, enabling us
to monitor cone density across two or more time points. The
largest available montage was chosen as the ‘‘reference’’
montage, to which all other montages were scaled and aligned.
ROIs were located manually, ensuring that the same locations
were assessed across imaging sessions. To correct for
differences in distortion between montages, follow-up images
were warped to the reference image using Fiji’s plugin,
bUnwarpJ.28 Due to changes in the size of montages acquired
across imaging sessions and sites, only ROIs at the fovea and at
0.258, 0.58, and 18 were used in longitudinal assessment. Cone
density was measured using both confocal and split-detection
modalities wherever possible. GraphPad Prism (La Jolla, CA,
USA) was used for statistical analysis.
RESULTS
A summary of the genotype and clinical phenotype for each
patient is given in the Table. Ten subjects were found to have
exon 3 haplotypes, seven with LIAVA and three with LVAVA. In
LIAVA, exon 3 is skipped and exon 2 is spliced directly to exon
4, the splicing defect has been shown to be ‘‘complete,’’
leading to a total lack of functional photopigment and a
stationary phenotype.15,29,30 In LVAVA, the splicing defect has
been shown to be ‘‘incomplete,’’ resulting in a small amount of
full-length mRNA and a small amount of functional photopig-
ment; although this has been associated with residual function,
protein toxicity can lead to progressive cone degeneration.14,15
Two subjects had exon 2 insertions, which can result in
alterations in secondary RNA structure, protein coding
sequences or splicing.31 The remaining subject had an exon
4 splice defect (IVS4þ1G>T).
Among subjects with LIAVA (n ¼ 7), axial length was
generally greater than for normal emmetropia (24.00 6 1.09
mm),33 with a mean 6 SD of 26.5 6 2.6 mm, although three of
these subjects (MM_0142, MM_0145, and MM_0157) were
within the normal range.
Retinal thickness was measured at the fovea for 12 subjects.
Total retinal thickness (180.516 18.74 lm) at the fovea ranged
from 69% to 97% of normal, while ONLþ thickness (79.64 6
FIGURE 1. Longitudinal OCT showed no evidence of retinal thinning at
the fovea over a follow-up period of 12 months in five subjects. Two
with LIAVA, two with an exon 2 insertion, and one with an exon 4
splice defect. Foveal scans are shown for each of the five subjects
analyzed on initial examination (left) and after 1 year (right). Scale bar:
100 lm.
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14.12 lm) ranged from 51% to 96% of normal.6 Additionally,
we analyzed retinal thickness over a 12-month period for five
subjects using OCT (Fig. 1). We found no evidence for change
in either total retinal thickness (P¼ 0.405) or ONLþ thickness
(P ¼ 0.392) at the fovea over the course of 12 months.
Cone density was examined in 11 of 13 subjects, while the
images obtained from the remaining two subjects were of
insufficient quality to enable accurate quantification; these
subjects were excluded from further analysis. Mean cone
density values from a single time point are shown grouped by
the type of mutation in Figure 2 (for all mean density values for
each subject at all available locations, see Supplementary Table
S1).
Due to changes in cone topography across the retina, the
density data did not have a normal distribution. After log
transformation, confocal data remained nonnormal (P < 0.01)
whereas the split-detection data passed the normality test (P¼
0.069). Given the borderline P value, we opted to use
nonparametric methods to compute the limits of agreement
in the Bland-Altman plots, shown in Figure 3. In the case of
confocal images, the discrepancy was larger when cone density
was low, whereas for split-detection, the discrepancy was
relatively constant. These effects are likely owing to increased
ambiguity at more eccentric locations; larger multimodal
cones, the presence of rods, and increased nystagmus are all
factors that impact the reliability of cone identification in
peripheral confocal images. The presence of a relationship
between density and the size of discrepancy using confocal
images suggests that cone identification using split-detection
images may be less susceptible to location-dependent changes
in accuracy. The intraclass correlation coefficient for the two
sets of split-detection (log) counts across all available locations
was 0.98 (subject SD ¼ 1.01, residual SD ¼ 0.14).
In agreement with previous findings,6 our subjects showed
variably reduced foveal density from normal (~85,000–
235,000 cones/mm2),26,34 with a mean 6 SD of 49,155 6
24,459 cones/mm2 (range, 19,061–90,970 cones/mm2) using
confocal images. Likewise, split-detection cone density (57,845
6 18,010 cones/mm2; range, 29,750–96,625 cones/mm2) fell
below the normal range for all but one subject (JC_0084, for
whom the LIAVA mutation was expressed by the second gene
in the array). However, density measured using split-detection
images was significantly greater than confocal (P < .0001,
Wilcoxon matched pairs t-test). A direct correspondence
FIGURE 2. Confocal (A) and split-detection (B) cone density values are shown grouped by type of mutation. Where there are data from more than
one subject, means and 2 SDs are shown. Cones were present in all ROIs for all analyzable subjects, therefore, the absence of bars or error bars
indicates that there was insufficient data. Density measured using split-detection was consistently higher than confocal images, indicating the
presence of nonwaveguiding cones.
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between dark gaps observed in confocal images and inner
segment structure in split-detection images can be seen in four
LIAVA subjects (Fig. 4) and one subject from each of the
remaining mutation types in (Fig. 5).
There was a statistically significant inverse relationship
between axial length and the proportion of foveal cones that
effectively waveguide light (calculated as confocal/split-detec-
tion counts3 100; P¼ 0.043, Spearman r¼ 0.70; Fig. 6), using
AOSLO data from nine subjects, indicating a correlation
between eye growth and the proportion of functioning cones
in the mosaic. Direct observation of the images for LIAVA
subjects in Figure 4 would also suggest that those with the
highest axial lengths have the fewest waveguiding cones.
Although retinal magnification and retinal stretching in myopia
has the potential to affect the conversion between angular and
retinal distance units, as well as the ‘‘true’’ number of cones,35
the proportion of cones that are visibly waveguiding is not
confounded by these factors.
No relationship was found between total retinal thickness
and foveal cone density as measured using either confocal (P¼
0.588) or split-detection images (P¼ 0.387). There was also no
relationship between ONLþ thickness and either confocal (P¼
0.770) or split-detection (P ¼ 0.710) foveal cone density.
We were able to obtain images at two or more time points
(6, 12, and/or 18 months) for six of 11 analyzable subjects
(MM_0142, MM_0144, MM_0145, MM_0156, MM_0157,
MM_0188). As there were more time points for which cone
density was quantifiable at 0.58 temporal, rather than at foveal
center, we used this location for longitudinal analysis (Fig. 7).
There were large fluctuations in cone density, with a mean 6
SD density increase of 2 6 12% for confocal and 21 6 33% for
split-detection images. Linear modeling revealed no significant
slope for either confocal (P ¼ 0.692) or split-detection (P ¼
0.485) modalities. For some subjects (JC_0084, JC_0609,
MM_0142, MM_0145, MM_0188), confocal imaging revealed
localized areas of reduced reflectivity that were not necessarily
present at all visits (Fig. 8).
FIGURE 3. Bland-Altman plot, showing the distribution of differences for repeated cone counts by the same observer. All retinal locations are
included in analysis, resulting in nonnormal distribution and subsequent log transformation. Bias (solid line) and nonparametric limits of agreement
(dotted lines) for both confocal (A) and split-detection (B) are shown. Cone identification shows a location-based bias in reliability, whereas split-
detection images show similar differences across the retina.
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FIGURE 4. Confocal (column 1) and split-detection (column 2) AOSLO images of the foveal center for four subjects with the LIAVA haplotype. Also
shown are color-merged images (column 3) in which amber represents the brightly reflective cones and rods visible in the confocal channel and
blue represents the structure shown in split-detection images. The subjects in the upper two rows have the shortest axial length (23.34 and 23.59
mm) and the subjects in the lower two rows have the longest (27.48 and 29.03 mm) of the analyzable LIAVA subcohort. The proportion of area
occupied by visibly waveguiding cones is higher for the subjects with shorter axial length than those with longer axial length, illustrating the
significant relationship found between axial length and waveguiding to nonwaveguiding cone ratio. Scale bar: 100 lm.
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DISCUSSION
The current study used high-resolution split-detection AOSLO
imaging to characterize the structural integrity of the retinal
mosaic in subjects with X-linked cone dysfunction. We present
the first definitive evidence of residual cone inner segments,
albeit with reduced density from normal, in those harboring
OPN1LW/OPN1MW mutations. This highlights the utility of
split-detection images (in which cones were identifiable
despite the absence of waveguiding) and contributes to the
growing body of work that has revealed inner segment
structure in various pathologies known to reduce or abolish
cone function.18,36
While, on average, we found no evidence of progressive
cone loss in subjects with LIAVA, exon 2 insertion, or exon 4
splice defect mutations, a limitation of this study was the
moderate fluctuation in measured cone density across time
points. Both modalities likely incurred errors in cone
identification as has been previously reported,27,37 with split-
detection showing higher variability than confocal values.
However, measurement error has been shown to be disease-
specific,36 and the split-detection data we present here are the
first of their kind for X-linked cone dysfunction. As this subject
population had relatively high foveal cone density when
compared with conditions like achromatopsia,18 the size of
parafoveal cones approached the resolution limit of split-
FIGURE 5. Confocal (column 1) and split-detection (column 2) AOSLO images of the foveal center for subjects with the exon 3 LVAVA haplotype,
exon 2 insertion, and exon 4 splice defect. Also shown are color-merged images (column 3) in which amber represents the brightly reflective cones
and rods visible in the confocal channel and blue represents the structures shown in split-detection images. Although the ratio of waveguiding to
nonwaveguiding cones is variable, similar overall appearance is observed across mutations. Scale bar: 100 lm.
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detection AOSLO, thereby increasing susceptibility to misiden-
tification. Although not significant, the overall trend for the
split-detection data was toward an increase in cone density, as
has been noted in other longitudinal studies.38 Image quality
can influence the accuracy of cone identification; nystagmus,
fixational stability, and subject cooperation all tend to improve
with a subject’s age and experience. This might suggest the
need to develop more extensive baseline testing similar to
those designed to account for learning effects in visual field
testing. For confocal AOSLO, changes in cone reflectivity over
time (Fig. 8) may be a source of error, though we tried to avoid
using ROIs containing large areas of low reflectivity. Even
within a single image, the high variability in cone reflectivity in
these subjects introduces uncertainty in differentiating be-
tween nonreflecting and dimly reflecting cones, which
impacts the accuracy of cone identification using confocal
AOSLO images. This is supported by recent work showing that
observers require less training to converge on agreement when
identifying cones using split-detection AOSLO compared with
confocal AOSLO.39 There is also evidence that observer
training and experience can significantly affect repeatability
in cone identification.36,39,40 As such, automated cone
detection techniques that use both confocal and split-detection
modalities may facilitate more objective and reliable quantifi-
cation.41
The LIAVA haplotype produces an exon 3 splicing defect,
this causes exon 2 to be spliced to exon 4 causing a reading
frameshift, resulting in a stop codon that subjects the mRNA to
nonsense mediated decay,30,42,43 thus accounting for the
complete absence of any measurable function of LIAVA-
expressing cones. Previous work indicates that the LVAVA
interchange mutation results in misfolded or dysfunctional
opsin and is associated with late onset cone degeneration.11,14
However, in stark contrast to previous reports of severe
localized degeneration of foveal photoreceptors in LVAVA
patients,6,11 split-detection images of the two brothers studied
here (JC_11437 and JC_11445) showed a contiguous foveal
cone mosaic. It is unclear whether this finding indicates a
particularly late onset of cone degeneration, as they are aged
36 and 26 years, respectively, or whether these brothers are
genuine examples of a more stationary LVAVA phenotype.
Comprehensive genetic analysis and longitudinal imaging using
a larger LVAVA cohort is necessary to determine the degree of
progression attributable this opsin variant.
This study lends insight into mechanisms underlying
myopia. The first reported AOSLO images from a person with
LIAVAwas a deuteranope with the mutation in the second gene
of the array (JC_0084).12 While the individual did have a mild
refractive error, other symptoms associated with X-linked cone
dysfunction (beyond the color defect) would be expected to
be minimal as, for the average Caucasian, more than two-thirds
of the cones express the first gene in the array.44 Six of seven
LIAVA patients reported here had the mutation in the first gene
in the array, and four of those had extremely high-grade myopia
with refractive errors predicted to average greater than 10
diopters; those who were analyzable also had fewer wave-
guiding cones. Similarly, of the two brothers with an exon 2
insertion, MM_0156 had the largest disparity in density
between modalities and also had a longer axial length.
Differences such as this between brothers with the same
FIGURE 6. The assumed proportion of foveal cones that effectively
waveguide light (calculated as confocal / split-detection counts3 100)
decreases with increasing axial length (P¼ 0.043, Spearman r¼ 0.70).
This inverse relationship lends support to the theory that the number
of nonfunctional cones within the retina plays a significant role in
myopia progression.
FIGURE 7. Parafoveal cone density at 0.58 temporal, assessed using
both confocal (A) and split-detection (B) modalities, showed no
significant change over an 18-month follow-up period for six subjects.
Three with LIAVA, two with an exon 2 insertion and one with an exon
4 splice defect. A linear model revealed no significant slope for either
confocal (P¼ 0.692) or split-detection (P¼ 0.485) density.
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genotype may be explained by differences in the relative
expression of first versus downstream genes in the array,
which is what typically produces individual differences in L/M
cone ratio among trichromatic individuals (even brothers).6 In
subjects MM_0142 and MM_0145, skewed/reduced expression
of the first gene (LIAVA) in their arrays (which would lead to a
low L/M cone ratio in normal individuals) likely results in
relatively few nonwaveguiding cones, hence their minimal
myopia. As the relative expression of first versus downstream
genes in the array is determined early in development,45 our
results suggest a causative relationship between the relative
fraction of nonfunctional/nonwaveguiding cones and myopia
severity. Previously, the relationship between myopia and the
activity of ON-bipolar cells has been noted.14 As shown here,
patients with an LIAVA opsin gene clearly have cone inner
segments where sodium is pumped out, but they lack
photopigment and visible outer segments where the cation
channels required for depolarization are normally located.
Thus, they are expected to be constitutively hyperpolarized,
preventing the release of glutamate required to inhibit ON-
bipolar cells. This would explain the correlation between the
number of LIAVA-expressing cones and myopia; the greater the
number of defective cones that cannot release glutamate
normally in the dark, the greater the disinhibition of ON-
bipolar signaling, which is responsible for signaling the eye to
grow.
The LIAVA haplotype has been previously associated with a
stationary phenotype.12–14 Similarly, the splice defect and
insertion studied here also introduce stop codons that would
signal nonsense–mediated decay of the mRNA, and thereby
predict a stationary phenotype, although, owing to the small
sample size, this finding has low statistical power. Future
longitudinal analysis should aim to include greater numbers of
subjects with each underlying mutation, as well as longer
duration of follow-up, to determine the therapeutic window
for these patients. Regardless, it appears from the results
presented here that cones devoid of opsin remain viable,
suggesting that many of these subjects may be appropriate
candidates for gene therapy efforts to restore cone function.
Acknowledgments
The authors thank Robert F. Cooper, Brian P. Higgins, Christopher
S. Langlo, Alex E. Salmon, Phyllis Summerfelt, and Melissa Wilk for
their contributions to this work. They also thank Sergey Tarima
and Alexis Visotcky for statistical support.
Supported by grants from the National Center for Research
Resources and the National Center for Advancing Translational
Sciences of the National Institutes of Health under award number
UL1TR001436 (Bethesda, MD, USA) and by the National Eye
Institute of the National Institutes of Health under award numbers
R01EY017607, R01EY021242, R01EY028118, P30EY001931,
P30EY001730 (Bethesda, MD, USA). This investigation was
conducted in part in a facility constructed with support from the
Research Facilities Improvement Program, grant number
C06RR016511 from the National Center for Research Resources,
National Institutes of Health (Bethesda, MD, USA). Additional
support came from an unrestricted grant from Research to Prevent
Blindness (New York, NY, USA), Foundation Fighting Blindness
(Columbia, MD, USA), Moorfields Special Trustees (London, UK),
Moorfields Eye Charity (London, UK), Fight for Sight (London, UK),
Medical Research Council (London, UK), and the National Institute
for Health Research Biomedical Research Centre at Moorfields Eye
Hospital NHS Foundation Trust and UCL Institute of Ophthalmol-
ogy (London, UK). MM is the recipient of a Career Development
Award from the Foundation Fighting Blindness.
Disclosure: E.J. Patterson, None; A. Kalitzeos, None; M.
Kasilian, None; J.C. Gardner, None; J. Neitz, None; A.J.
Hardcastle, None; M. Neitz, None; J. Carroll, None; M.
Michaelides, None
References
1. Haim M, Fledelius HC, Skarsholm D. X-linked myopia in a
Danish family. Acta Ophthalmol. 1988;66:450–456.
FIGURE 8. Confocal AOSLO (upper row) reveals distinct patches of reduced cone reflectivity, which, by itself, might indicate changes over time.
However, split-detection imaging (lower row) enables visualization of intact cone inner segments within these areas of low reflectivity.
Furthermore, split-detection images, unlike confocal, show perfect registration across timepoints, highlighting the utility of this imaging modality,
particularly in longitudinal assessment. Images are from MM_0142 (LIAVA) and MM_0188 (exon 4 splice defect) at approximately 18 from the foveal
center. Scale bar: 25 lm.
Cone Structure and X-Linked Cone Opsin Mutations IOVS j August 2018 j Vol. 59 j No. 10 j 4246
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937431/ on 08/24/2018
2. Schwartz M, Haim M, Skarsholm D. X-linked myopia:
Bornholm eye disease. Linkage to DNA markers on the distal
part of Xq. Clin Genet. 1990;38:281–286.
3. Aboshiha J, Dubis AM, Carroll J, Hardcastle AJ, Michaelides M.
The cone dysfunction syndromes. Br J Ophthalmol. 2016;
100:115–121.
4. Young TL, Deeb SS, Ronan SM, et al. X-linked high myopia
associated with cone dysfunction. Arch Ophthalmol. 2004;
122:897–908.
5. McClements M, Davies WI, Michaelides M, et al. Variations in
opsin coding sequences cause X-linked cone dysfunction
syndrome with myopia and dichromacy. Invest Ophthalmol
Vis Sci. 2013;54:1361–1369.
6. Patterson EJ, Wilk M, Langlo CS, et al. Cone photoreceptor
structure in patients with X-linked cone dysfunction and red-
green color vision deficiency. Invest Ophthalmol Vis Sci.
2016;57:3853–3963.
7. Neitz J, Neitz M. The genetics of normal and defective color
vision. Vision Res. 2011;51:633–651.
8. Guo X, Xiao X, Li S, Wang P, Jia X, Zhang Q. Nonsyndromic
high myopia in a Chinese family mapped to MYP1: linkage
confirmation and phenotypic characterization. Arch Ophthal-
mol. 2010;128:1473–1479.
9. Li J, Gao B, Guan L, et al. Unique variants in OPN1LW cause
both syndromic and nonsyndromic X-linked high myopia
mapped to MYP1. Invest Ophthalmol Vis Sci. 2015;56:4150–
4155.
10. Ratnamala U, Lyle R, Rawal R, et al. Refinement of the X-
linked nonsyndromic high-grade myopia locus MYP1 on Xq28
and exclusion of 13 known positional candidate genes by
direct sequencing. Invest Ophthalmol Vis Sci. 2011;52:6814–
6819.
11. Carroll J, Dubra A, Gardner JC, et al. The effect of cone opsin
mutations on retinal structure and the integrity of the
photoreceptor mosaic. Invest Ophthalmol Vis Sci. 2012;53:
8006–8015.
12. Carroll J, Neitz M, Hofer H, Neitz J, Williams DR. Functional
photoreceptor loss revealed with adaptive optics: an alternate
cause of color blindness. Proc Natl Acad Sci U S A. 2004;101:
8461–8466.
13. Neitz M, Carroll J, Renner A, Knau H, Werner JS, Neitz J.
Variety of genotypes in males diagnosed as dichromatic on a
conventional clinical anomaloscope. Vis Neurosci. 2004;21:
205–216.
14. Greenwald SH, Kuchenbecker JA, Rowlan JS, Neitz J, Neitz M.
Role of a dual splicing and amino acid code in myopia, cone
dysfunction and cone dystrophy associated with L/M opsin
interchange mutations. Trans Vis Sci Tech. 2017;6(3):2.
15. Gardner JC, Liew G, Quan YH, et al. Three different cone
opsin gene array mutational mechanisms with genotype-
phenotype correlation and functional investigation of cone
opsin variants. Hum Mutat. 2014;35:1354–1362.
16. Cideciyan AV, Hufnagel RB, Carroll J, et al. Human cone visual
pigment deletions spare sufficient photoreceptors to warrant
gene therapy. Hum Gene Ther. 2013;24:993–1006.
17. Scoles D, Sulai YN, Langlo CS, et al. In vivo imaging of human
cone photoreceptor inner segments. Invest Ophthalmol Vis
Sci. 2014;55:4244–4251.
18. Langlo CS, Patterson EJ, Higgins BP, et al. Residual foveal cone
structure in CNGB3-associated achromatopsia. Invest Oph-
thalmol Vis Sci. 2016;57:3984–3995.
19. Scoles D, Flatter JA, Cooper RF, et al. Assessing photoreceptor
structure associated with ellipsoid zone disruptions visualized
with optical coherence tomography. Retina. 2016;36:91–103.
20. Luo X, Cideciyan AV, Iannaccone A, et al. Blue cone
monochromacy: visual function and efficacy outcome mea-
sures for clinical trials. PLoS One. 2015;10:e0125700.
21. Cideciyan AV, Roman AJ, Jacobson SG, et al. Developing an
outcome measure with high luminance for optogenetics
treatment of severe retinal degenerations and for gene
therapy of cone diseases. Invest Ophthalmol Vis Sci. 2016;
57:3211–3221.
22. Carroll J, Baraas RC, Wagner-Schuman M, et al. Cone
photoreceptor mosaic disruption associated with Cys203Arg
mutation in the M-cone opsin. Proc Natl Acad Sci U S A.
2009;106:20948–20953.
23. Rodriguez-Carmona ML, Harlow AJ, Walker G, Barbur JL. The
variability of normal trichromatic vision and the establish-
ment of the ‘‘normal’’ range. In: Proceedings of 10th
Congress of the International Colour Association. Granada:
International Colour Association. 2005;979–982.
24. Wilk MA, Wilk BM, Langlo CS, Cooper RF, Carroll J. Evaluating
outer segment length as a surrogate measure of peak foveal
cone density. Vision Res. 2017;130:57–66.
25. Dubra A, Harvey Z. Registration of 2D images from fast
scanning ophthalmic instruments. In: Fischer B, Dawant B,
Lorenz C, eds. Biomedical Image Registration. Berlin:
Springer-Verlag; 2010:60–71.
26. Wilk MA, McAllister JT, Cooper RF, et al. Relationship between
foveal cone specialization and pit morphology in albinism.
Invest Ophthalmol Vis Sci. 2014;55:4186–4198.
27. Garrioch R, Langlo C, Dubis AM, Cooper RF, Dubra A, Carroll
J. Repeatability of in vivo parafoveal cone density and spacing
measurements. Optom Vis Sci. 2012;89:632–643.
28. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-
source platform for biological-image analysis. Nat Methods.
2012;9:676–682.
29. Buena-Atienza E, Ru¨ther K, Baumann B, et al. De novo
intrachromosomal gene conversion from OPN1MW to
OPN1LW in the male germline results in Blue Cone
Monochromacy. Sci Rep. 2016;6:28253.
30. Ueyama H, Muraki-Oda S, Yamade S, et al. Unique haplotype
in exon 3 of cone opsin mRNA affects splicing of its
precursor, leading to congenital color vision defect. Biochem
Biophys Res Commun. 2012;424:152–157.
31. Akimitsu N. Messenger RNA surveillance systems monitoring
proper translation termination. J Biochem. 2008;143:1–8.
32. Michaelides M, Johnson S, Bradshaw K, et al. X-linked cone
dysfunction syndrome with myopia and protanopia. Ophthal-
mology. 2005;112:1448–1454.
33. Oyster CW. The Human Eye: Structure and Function.
Sunderland, MA: Sinauer Associates, Inc.; 1999.
34. Zhang T, Godara P, Blancob ER, et al. Variability in human
cone topography assessed by adaptive optics scanning laser
ophthalmoscopy. Am J Ophthalmol. 2015;160:290–300.
35. Li KY, Tiruveedhula P, Roorda A. Intersubject variability of
foveal cone photoreceptor density in relation to eye length.
Invest Ophthalmol Vis Sci. 2010;51:6858–6867.
36. Tanna P, Kasilian M, Strauss R, et al. Reliability and
repeatability of cone density measurements in patients with
Stargardt disease and RPGR-associated retinopathy. Invest
Ophthalmol Vis Sci. 2017;58:3608–3615.
37. Talcott KE, Ratnam K, Sundquist S, et al. Longitudinal study of
cone photoreceptors during retinal degeneration and in
response to ciliary neurotrophic factor treatment. Invest
Ophthalmol Vis Sci. 2011;52:2219–2226.
38. Langlo CS, Erker LR, Parker M, et al. Repeatability and
longitudinal assessment of foveal cone structure in CNGB3-
associated achromatopsia. Retina. 2017;37:1956–1966.
39. Morgan JIW, Vergilio GK, Hsu J, Dubra A, Cooper RF. The
reliability of cone density measurements in the presence of
rods. Trans Vis Sci Tech. 2018;7(3):21.
40. Abozaid MA, Langlo CS, Dubis AM, Michaelides M, Tarima S,
Carroll J. Reliability and repeatability of cone density
Cone Structure and X-Linked Cone Opsin Mutations IOVS j August 2018 j Vol. 59 j No. 10 j 4247
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937431/ on 08/24/2018
measurements in patients with congenital achromatopsia.
Adv Exp Med Biol. 2016;854:277–283.
41. Cunefare D, Fang L, Cooper RF, Dubra A, Carroll J, Farsiu S.
Open source software for automatic detection of cone
photoreceptors in adaptive optics ophthalmoscopy using
convolutional neural networks. Sci Rep. 2017;7:6620.
42. Nguyen LS, Wilkinson MF, Gecz J. Nonsense-mediated mRNA
decay: inter-individual variability and human disease. Neuro-
sci Biobehav Rev. 2014;46:175–186.
43. Chang B, Mandal MN, Chavali VR, et al. Age-related retinal
degeneration (arrd2) in a novel mouse model due to a
nonsense mutation in the Mdm1 gene. Hum Mol Genet. 2008;
17:3929–3941.
44. Carroll J, Neitz J, Neitz M. Estimates of L:M cone ratio from
ERG flicker photometry and genetics. J Vis. 2002;2(8):531–
542.
45. Bumsted K, Jasoni C, Szel A, Hendrickson A. Spatial and
temporal expressions of cone opsins during monkey retinal
development. J Comp Neurol. 1997;378:117–134.
Cone Structure and X-Linked Cone Opsin Mutations IOVS j August 2018 j Vol. 59 j No. 10 j 4248
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/937431/ on 08/24/2018
 Supplementary Materials 
 
Supplementary Table 1. A) Confocal cone density for subjects with X-linked cone dysfunction 
Subject Mutation Fovea 0.25° T 0.5° T 1° T 2° T 3° T 4° T 5° T 6° T 7° T 8° T 9° T 10° T 
JC_0084 LIAVA 90,970 76,179 52,855 30,163 12,876 14,318 8,953 7,165 9,516 7,156 5,406 6,148 4,729 
MM_0133 LIAVA 28,955 12,642 7,547 7,602 7,615 2,146 -- -- -- -- -- -- -- 
MM_0142 LIAVA 52,229 43,299 33,665 23,702 13,240 8,682 2,766 3,544 6,392 5,102 4,158 2,791 -- 
MM_0144 LIAVA 30,585 22,069 22,758 21,700 -- -- -- -- -- -- -- -- -- 
MM_0145 LIAVA 61,666 45,653 31,016 20,294 12,976 9,533 2,228 3,999 3,915 5,481 3,315 3,668 -- 
MM_0155 LIAVA -- -- -- -- -- -- -- -- -- -- -- -- -- 
JC_0609 LIAVA 19,061 14,086 10,197 7,232 2,232 3,559 3,016 4,237 5,024 2,149 1,157 1,653 2,760 
JC_10340 LVAVA -- -- -- -- -- -- -- -- -- -- -- -- -- 
JC_11437 LVAVA 75,229 54,358 40,808 27,224 3,330 -- 6,065 5,199 5,830 5,881 3,057 2,958 2,314 
JC_11445 LVAVA -- -- -- 21,590 12,446 8,056 5,209 5,051 2,810 6,262 3,695 4,183 1,653 
MM_0156 
exon 2 
insertion 
20,664 23,504 16,083 15,495 11,603 6,879 4,511 5,216 2,149 4,099 5,077 -- -- 
MM_0157 
exon 2 
insertion 
67,566 56,030 37,059 25,736 15,027 10,724 -- -- -- -- -- -- -- 
MM_0188 
exon 4  
splice defect 
44,626 37,156 25,599 16,032 -- -- -- -- -- -- -- -- -- 
               
Supplementary Table 1. B) Split-detection cone density for subjects with X-linked cone dysfunction 
Subject Mutation Fovea 0.25° T 0.5° T 1° T 2° T 3° T 4° T 5° T 6° T 7° T 8° T 9° T 10° T 
JC_0084 LIAVA 96,625 85,337 68,916 42,140 30,787 17,534 11,417 9,726 7,857 7,444 6,759 4,666 4,852 
MM_0133 LIAVA 47,391 43,088 32,009 28,876 13,212 8,270 -- -- -- -- -- -- -- 
MM_0142 LIAVA 66,475 58,196 38,504 22,120 12,783 10,853 5,301 4,924 6,453 5,974 3,952 3,433 -- 
MM_0144 LIAVA 59,222 42,916 22,231 17,561 -- -- -- -- -- -- -- -- -- 
MM_0145 LIAVA 55,999 57,797 40,443 18,744 14,632 5,203 5,524 6,543 4,366 3,429 3,179 4,468 -- 
MM_0155 LIAVA -- -- -- -- -- -- -- -- -- -- -- -- -- 
JC_0609 LIAVA 29,750 24,111 23,842 16,965 10,747 6,399 3,689 1,733 2,314 3,395 3,223 3,889 2,645 
JC_10340 LVAVA -- -- -- -- -- -- -- -- -- -- -- -- -- 
JC_11437 LVAVA -- 60,981 51,037 30,668 16,236 9,482 9,798 7,834 7,323 9,679 5,785 7,715 4,071 
JC_11445 LVAVA -- -- -- 37,891 18,946 13,365 11,111 7,622 5,898 6,060 6,488 6,650 5,192 
MM_0156 
exon 2 
insertion 
52,938 42,473 30,533 22,123 11,445 7,260 3,876 4,263 3,682 3,252 4,365 -- -- 
MM_0157 
exon 2 
insertion 
62,527 57,070 36,943 25,116 16,933 6,657 -- -- -- -- -- -- -- 
MM_0188 
exon 4  
splice defect 
49,678 42,600 32,610 22,526 4,934 -- -- -- -- -- -- -- -- 
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